CNS
Overvalued by 51.1% based on the discounted cash flow analysis.
Market cap | $3.73 Billion |
---|---|
Enterprise Value | $3.63 Billion |
Dividend Yield | $2.2911 (3.11%) |
Earnings per Share | $2.57 |
Beta | 1.4 |
Outstanding Shares | 50,540,398 |
Avg 30 Day Volume | 583,666 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 29.18 |
---|---|
PEG | -786.7 |
Price to Sales | 8.15 |
Price to Book Ratio | 10.47 |
Enterprise Value to Revenue | 7.46 |
Enterprise Value to EBIT | 21.93 |
Enterprise Value to Net Income | 28 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data